A dozen members of Congress called on Health and Human Services Secretary Xavier Becerra to seize the patent for Xtandi, a popular prostate cancer drug earlier this year. They say it costs too much.
A dozen members of Congress called on Health and Human Services Secretary Xavier Becerra to seize the patent for Xtandi, a popular prostate cancer drug earlier this year. They say it costs too much.